Abstract
The course of 260 adults with haematological malignancies admitted to a medical intensive care unit was studied to evaluate the value of life support techniques and to research predictive factors. The overall in the medical intensive care unit (MICU) and hospital mortality rates were respectively 43% (113 patients) and 57% (148 patients). Among survivors, 64% (49 patients) were still alive after 6 months and 44% (35 patients) after 1 year. Among 34 haemodialysed patients, the MICU mortality was 67% (23 patients) and among 111 mechanically ventilated patients 85% (94 patients). Prolonged mechanical ventilation, more than seven days, was performed in 11 of the 17 survivors and did not influence long term survival. No individual predictor of mortality was found comparing survivors and non-survivors. However, SAPS, intractable sepsis and failure of more than one organ system were significantly different in non-survivors (p<0.001). Among the 20 patients requiring both mechanical ventilation and haemodialysis, only two left the MICU and both died soon thereafter. We conclude that life support therapy should be initiated in patients with haematological disorders and that prolonged mechanical ventilation is compatible with long term survival. However, the combination of mechanical ventilation and haemodialysis is always associated with a poor prognosis and therefore the use of both techniques simultaneously for one patient is questionable.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Young LS (1988) Management of infections in leukemia and lymphoma. In: Rubin RH, Young LS (eds) Clinical approach to infection in the compromised host, 2nd edn. Plenum Publishing Corporation, New York, pp 467–501
Cullen DJ, Ferrata LC, Briggs BA, Walter PF, Gilbert J (1976) Survival, hospitalization charges and follow-up results in critically ill patients. N Engl J Med 294:982–987
Turnbull A, Carlon G, Baron R, Sichel W, Young C, Howland W (1979) The inverse relationship between cost and survival in the critically ill cancer patient. Crit Care Med 7:20–23
Byrick RJ, Mindorff C, McKee J, Mudge B (1980) Cost-effectiveness of intensive care for respiratory failure patients. Crit Care Med 8:332–337
Schuster DP, Marion JM (1983) Frecedents for meaningful recovery during treatment in a medical intensive care unit. Am J Med 75:42–408
Estopa R, Torres Marti A, Kastanos N, Rives A, Agusti-Vidal A, Rozman C (1984) Acute respiratory failure in severe hematologic disorders. Crit Care Med 12:26–28
Lloyd-Thomas AR, Dhaliwal HS, Lister TA, Hinds CJ (1986) Intensive therapy for life-threatening medical complications of haematological malignancy. Intensive Care Med 12:317–324
Denardo SJ, Oye RK, Bellamy PE (1989) Efficacy of intensive care for bone marrow transplant patients with respiratory failure. Crit Care Med 17:4–6
Snow RM, Miller WC, Rice DL, Ali MK (1979) Respiratory failure in cancer patients. JAMA 241:2039–2042
Crawford SW, Schwartz DA, Petersen FB, Clark JG (1988) Mechanical ventilation after marrow transplantation. Risk factors and clinical outcome. Am Rev Respir Dis 137:682–687
Le Gall JR, Loirat P, Alperovitch A, Glaser P, Granthil C, Mathieu D, Mercier P, Thomas R, Villers D (1984) Am simplified acute physiology score for ICU patients. Crit Care Med 12:975–977
Ognibene FP, Martin SE, Parker MM, Schlesinger T, Roach P, Burch C, Shelhamer JH, Parillo JE (1986) Adult respiratory distress syndrome in patients with severe neutropenia. N Engl J Med 315:547–551
Casati S, Graziani G, Ponticelli C (1982) Hemodialysis without anticoagulant in patients with high bleeding risk. Int J Artif Organs 5:233–236
Groeger JS (1985) Shock states and cancer. In: Howland WS, Carlon GC (eds) Critical care of the cancer patient. Year Book Medical Publishers, Chicago, pp 296–317
Pizzo PA, Hathorn JW, Hiemenz J, Browne M, Commers J, Cotton D, Gress J, Longo D, Marshall D, McKnight J, Rubin M, Skelton J, Thaler M, Wesley R (1986) A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia. N Engl J Med 315:552–558
Cordonnier C, Bernaudin JF, Fleury J, Feuilhade M, Haioun C, Payen D, Huet Y, Atassi K, Vernant JP (1985) Diagnostic yield of bronchoalveolar lavage in pneumonitis occurring after allogeneic bone marrow transplantation. Am Rev Respir Dis 132:1118–1132
Chastre J, Viau F, Brun P, Pierre J, Dauge MC, Bouchama A, Akesbi A, Gibert C (1984) Prospective evaluation of the protected specimen brush for the diagnosis of pulmonary infections in ventilated patients. Am Rev Respir Dis 130:924–929
Di-Nubile MJ (1985) Therapeutic role of granulocyte transfusions. Rev Infect Dis 7:232–243
Rothman KJ (1978)_Estimation of confidence limits for the cumulative probability of survival in life table analysis. J Chron Dis 557–560
Swets JA (1979) ROC analysis applied to the evaluation of medical imaging techniques. Invest Radiol 14:109–121
Cullen DJ, Civetta JM, Briggs BA, Ferrata LC (1974) Therapeutic intervention scoring system — a method for quantitative comparison of patient care. Crit Care Med 2:57–60
Loirat P, Gayraud M, Rigattieri S, Bonnet F, Legall JR (1983) Comparison of three severity score indexes in acute hemorrhagic pacreatitis. Intensive Care Med 9:236–237
Gillespie DJ, Marsh HMM, Divertie MB, Meadows JA (1986) Clinical outcome of respiratory failure in patients requiring prolonged (>24 hours) mechanical ventilation. Chest 90:364–369
Baumann WR, Jung RC, Koss M, Boylen T, Navarro L, Sharma OP (1986) Incidence and mortality of adult respiratory distress syndrome: a prospective analysis from a large metropolitan hospital. Crit Care Med 14:1–4
Bartlett RH, Gayzaniga AB, Wilson AF (1975) Mortality prediction in adult respiratory insufficiency. Chest 67:680–684
Knaus WA, Le Gall JR, Wagner DP, Draper EA, Loirat P, Campos RA, Cullen DJ, Kohles MK, Glaser P, Granthil C, Mercier P, Nicolas F, Nikki P, Shin B, Snyder JV, Wattel F, Zimmerman JE (1982) A comparison of intensive care in the USA and France. Lancet II:642–646
Knaus WA, Draper EA, Wagner DP, Zimmerman JE (1982) Evaluating outcome from intensive care: a preliminary multihospital comparison. Crit Care Med 10:491–496
Prakash UB, Divertie MB, Banks PM (1979) Aggressive therapy in acute respiratory failure from leukemic pulmonary infiltrates. Chest 75:345–350
Ashkenazi YJ, Kramer BS, Harman E (1986) Short-term outcome among patients with leukemia and lymphoma admitted to a medical intensive care unit. South Med J 79:1086–1088
Turbull A, Goldiner P, Silverman D, Howland W (1976) The role of an intensive care unit in a cancer center. Cancer 37:82–84
Hauser MJ, Tabak J, Baier H (1982) Survival of patients with cancer in a medical critical care unit. Arch Intern Med 142:527–529
Ewer MS, Ali MK, Atta MS, Morice RC, Balakrishman PV (1986) Outcome of lung cancer patients requiring mechanical ventilation for pulmonary failure. JAMA 256:3354–3366
Carlon GC (1978) Acute respiratory failure in cancer patients. Curr Probl Cancer 4:47–57
Flombaum C (1985) Electrolyte and renal abnormalities in the cancer patient. In: Howland WS, Carlton GC (eds) Critical care of the cancer patient. Year Book Medical Publishers, Chicago, pp 114–142
The French Multicenter Group of ICU Research; the INSERM UNIT 169 of Statistical and Epidemiological Studies (1989) Factors related to outcome in intensive care: French multicenter study. Crit Care Med 17:305–308
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Brunet, F., Lanore, J.J., Dhainaut, J.F. et al. Is intensive care justified for patients with haematological malignancies?. Intensive Care Med 16, 291–297 (1990). https://doi.org/10.1007/BF01706352
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01706352